As of July 2024, we found 3 studies recruiting participants for addiction-related conditions
Koloverou E, Esposito K, Giugliano D, Panagiotakos D
La duracin del tratamiento con agonistas GLP-1 se determina individualmente segn la respuesta clnica, tolerabilidad y objetivos teraputicos
These medications work through several mechanisms
These signs indicate the situation has moved beyond self-management: Inability to keep any fluid down for more than 12-24 hours Urine output dropping to less than 400 mL in 24 hours (oliguria) Confusion, excessive sleepiness, or inability to stand without dizziness Serum creatinine rise of 0.3 mg/dL or more above baseline (meeting KDIGO AKI criteria) Resting heart rate above 120 beats per minute The National Kidney Foundation's KDIGO 2012 AKI guideline defines AKI stage 1 as a serum creatinine increase of 0.3 mg/dL within 48 hours or a rise to 1.5 times baseline within 7 days [10]
Engaging in regular physical activity also helps stimulate bowel function and support healthy digestion, which can help manage constipation, a common GLP-1 medication side effect